Dalal Nesheiwat, PharmD
Dalal Nesheiwat, PharmD
As Head of R&D Operations, Dalal is accountable for efficient internal workings of the R&D function. Select capabilities are centralized across R&D to drive efficient and effective R&D business outcomes, including but not limited to Global R&D Leadership Team Leadership and Office, End-to-End non-project initiatives, Standard Operating Procedure management, Change & Enablement, R&D communications, Globalization, R&D Learning & Development, Global Development Information Management and Global R&D Digital Transformation Management, and Japan R&D Management.
Over the past 3 years at Daiichi Sankyo, Dalal has successfully built and globalized the Clinical Science function across early and late phase development. Prior to joining Daiichi Sankyo, Dalal served in a broad range of global clinical development, regulatory submission management and clinical program leadership roles across hematology, oncology, endocrinology and rare diseases. Dalal’s accomplishments throughout a dynamic career at Bristol Myers Squibb, Celgene, Kyowa Kirin and Novartis include leading and supporting teams for several approvals in the U.S. and Europe and leading a global product launch in the U.S., Europe and Japan.
Dalal has a passion for creating her own path while making a positive impact on our patients’ lives one day at a time.